Antiparasitic Drugs
Economic Realities Depleting Arsenal
Published in Medical Letter on the CDC and FDA, November 12th, 2000
Many drugs still effective against parasitic diseases are either no longer available, no longer manufactured, or in danger of being pulled from the market simply because they are not economically viable, say researchers from the Baylor College of Medicine and the U.S. Centers for Disease Control and Prevention (CDC) at a presentation during the annual meeting of the American Society of Tropical Medicine and Hygiene in October 2000.
"Parasites are a very common causes of disease in the world but because there is no market for...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Adolescent Health
Effects of Dating Violence Studied - Diet and Nutrition
High Iron Levels Don't Increase Risk of Death from Heart Disease - Diet and Nutrition
Lack of Folic Acid Continues to Cause Preventable Birth Defects - Food-Borne Pathogens
Public Health Policies Successful in Limiting Salmonella - Gulf War Syndrome
It's Still a Mystery - Insurance
Many Uninsured Adults Do Not Receive Needed Medical Care - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
